82 FR 16159 - Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico, Notification of Proposed Production Activity, MSD International GMBH (Puerto Rico Branch) LLC, (Pharmaceuticals), Las Piedras, Puerto Rico

DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board

Federal Register Volume 82, Issue 62 (April 3, 2017)

[Federal Register Volume 82, Number 62 (Monday, April 3, 2017)]
[Notices]
[Page 16159]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-06533]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-19-2017]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico, Notification 
of Proposed Production Activity, MSD International GMBH (Puerto Rico 
Branch) LLC, (Pharmaceuticals), Las Piedras, Puerto Rico

    MSD International GMBH (Puerto Rico Branch) LLC (MSD), operator of 
Subzone 7G, submitted a notification of proposed production activity to 
the FTZ Board for its facility in Las Piedras, Puerto Rico within 
Subzone 7G. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on March 28, 
2017.
    MSD already has authority to produce certain pharmaceutical 
products within Subzone 7G. The current request would add a finished 
pharmaceutical product and a foreign status material/component to the 
scope of authority. Pursuant to 15 CFR 400.14(b), FTZ activity would be 
limited to the specific foreign-status materials and components and 
specific finished products described in the submitted notification (as 
described below) and subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt MSD from customs duty 
payments on the foreign-status components used in export production. On 
its domestic sales, MSD would be able to choose the duty rates during 
customs entry procedures that apply to anacetrapib pharmaceutical 
tablets for treatment of cardiovascular disease (duty free) for the 
foreign-status material/component noted below. Customs duties also 
could possibly be deferred or reduced on foreign-status production 
equipment.
    The component/material sourced from abroad is anacetrapib (duty 
rate 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary at the address 
below. The closing period for their receipt is May 15, 2017.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at 
[email protected] or (202) 482-1963.

    Dated: March 29, 2017.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2017-06533 Filed 3-31-17; 8:45 am]
 BILLING CODE 3510-DS-P